Regulation of alternative pathway activation and C3a production by adipose cells

被引:34
作者
Choy, LN [1 ]
Spiegelman, BM [1 ]
机构
[1] HARVARD UNIV, SCH MED, DEPT BIOL CHEM & MOL PHARMACOL, DANA FARBER CANC INST, BOSTON, MA 02115 USA
来源
OBESITY RESEARCH | 1996年 / 4卷 / 06期
关键词
acylation stimulating protein; adipsin; Crry/p65; properdin; obesity;
D O I
10.1002/j.1550-8528.1996.tb00266.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Adipose tissue is re major source of adpisin/factor D of the alternative pathway of complement. Adipose tissue also expresses the two other complement components which are involved in the first activation step of the alternative pathway, factor B and C3, and this step is activated in adipose tissue, producing C3a/Acylation Stimulating Protein (C3a/ASP), a stimulator of triglyceride synthesis, Complement activation is a highly regulated process, however, nothing is known about regulation of complement activation in adipose tissue, To gain insight into the nature of adipose complement activation and its regulation, we have now examined the expression of several complement activation regulatory genes, and analyzed the production of C3a/ASP in lean vs, obese, adipsin-deficient mice, We found that undifferentiated preadipocytes expressed the mRNAs encoding the negative regulatory proteins Crry and factor H, but expression of both genes was decreased upon differentiation, The positive regulator properdin, as well as Crry and factor ii, were found in adipose tissue, None of these genes was regulated in murine genetic obesity, To investigate the relative levels of complement activation in lean vs, adipsin-deficient obese mice, we developed a radioimmunoassay for measurement of murine C3a/ASP in plasma, We report that there was no significant difference in the level of C3a in lean vs, obese plasma; however, we found a positive correlation between C3a and plasma triglyceride levels in normal lean mice.
引用
收藏
页码:521 / 532
页数:12
相关论文
共 47 条
[1]  
Ausubel FA, 1995, CURRENT PROTOCOLS MO
[2]   THE ADIPSIN ACYLATION STIMULATING PROTEIN SYSTEM AND REGULATION OF INTRACELLULAR TRIGLYCERIDE SYNTHESIS [J].
BALDO, A ;
SNIDERMAN, AD ;
STLUCE, S ;
AVRAMOGLU, RK ;
MASLOWSKA, M ;
HOANG, B ;
MONGE, JC ;
BELL, A ;
MULAY, S ;
CIANFLONE, K .
JOURNAL OF CLINICAL INVESTIGATION, 1993, 92 (03) :1543-1547
[3]   CELL-SURFACE PROTEINS REACTING WITH ACTIVATED COMPLEMENT COMPONENTS [J].
BECHERER, JD ;
ALSENZ, J ;
SERVIS, C ;
MYONES, BL ;
LAMBRIS, JD .
COMPLEMENT AND INFLAMMATION, 1989, 6 (03) :142-165
[4]   HYPOTHALAMIC AND GENETIC OBESITY IN EXPERIMENTAL-ANIMALS - AUTONOMIC AND ENDOCRINE HYPOTHESIS [J].
BRAY, GA ;
YORK, DA .
PHYSIOLOGICAL REVIEWS, 1979, 59 (03) :719-809
[5]  
BROOIMANS RA, 1989, J IMMUNOL, V142, P2024
[6]  
CHENOWITH DE, 1980, FUTURE PERSPECTIVES, P443
[7]   ISOLATION OF BIOLOGICALLY-ACTIVE RIBONUCLEIC-ACID FROM SOURCES ENRICHED IN RIBONUCLEASE [J].
CHIRGWIN, JM ;
PRZYBYLA, AE ;
MACDONALD, RJ ;
RUTTER, WJ .
BIOCHEMISTRY, 1979, 18 (24) :5294-5299
[8]  
CHOY LN, 1992, J BIOL CHEM, V267, P12736
[9]  
CIANFLONE KM, 1989, J BIOL CHEM, V264, P426
[10]   Serum immunoreactive leptin concentrations in normal-weight and obese humans [J].
Considine, RV ;
Sinha, MK ;
Heiman, ML ;
Kriauciunas, A ;
Stephens, TW ;
Nyce, MR ;
Ohannesian, JP ;
Marco, CC ;
McKee, LJ ;
Bauer, TL ;
Caro, JF .
NEW ENGLAND JOURNAL OF MEDICINE, 1996, 334 (05) :292-295